TCR gamma/delta Antibody (7A5)
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-22510
Key Product Details
Species Reactivity
Validated:
Human, Drosophila, Primate
Applications
Block/Neutralize, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 7A5
Concentration
0.15 mg/ml
Product Summary for TCR gamma/delta Antibody (7A5)
Immunogen
Human TCR Vgamma9
Reactivity Notes
Fruit Fly reactivity reported in scientific literature (see J Immunol. 2008 Oct 1).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for TCR gamma/delta Antibody (7A5)
Western Blot: TCR gamma/delta Antibody (7A5) [NBP2-22510]
Western Blot: TCR gamma/delta Antibody (7A5) [NBP2-22510] - Analysis of 25 ug of CEM cell lysates.Flow Cytometry: TCR gamma/delta Antibody (7A5) [NBP2-22510]
Flow Cytometry: TCR gamma/delta Antibody (7A5) [NBP2-22510] - Analysis of TCR V gamma 9 in Jurkat cells (green) compared to an isotype control (blue).Applications for TCR gamma/delta Antibody (7A5)
Application
Recommended Usage
Flow Cytometry
2 ug
Immunocytochemistry/ Immunofluorescence
1:10 - 1:500
Immunohistochemistry
1:10-1:500
Immunoprecipitation
1:10 - 1:500
Western Blot
1:1 - 1:100
Application Notes
ICC/IF usage was reported in scientific literature (PMID: 1705662). IHC-Fr has been reported by customers with mixed results - 1:10 dilution.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS with 0.5% BSA
Preservative
0.1% Sodium Azide
Concentration
0.15 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: TCR gamma/delta
In humans, T cells expressing TCR gamma delta represents ~1-5% of total T cells in the peripheral blood but can comprise up to 50% of lymphoid cells in peripheral tissues like the intestines or dermis (3). The TCR gamma delta lineage arises from the double negative 3 (DN3) (CD44-,CD25-) stage of development where the cells receive strong TCR signals for gamma/delta selection (2). In contrast to alpha/beta T cells which are CD4+/CD8+, most gamma delta T cells are CD4-/CD8- (2). Gamma delta T cells produce different cytokines in response to varying degrees of signal received through the gamma delta TCR: a weaker signal induces interleukin (IL)-17, a moderate signal induces interferon (IFN)-gamma, and a strong signal stimulates IL-4 production (2,4). There are multiple gamma delta T cell subsets which are defined by the variable segments of the gamma and delta chain present after gene rearrangement (1,3,5). For example, Vgamma9Vdelta2 (Vgamma9Vdelta2) TCRs are expressed on the main subset of gamma delta T cells in human blood (1,3,5). Human gamma delta T cells expressing Vgamma9Vdelta2 TCR recognizes phosphoantigens that are released by tumor cells (3). The phosphoantigens bind butyrophilin (BTN) family members, such as BTN3A1/CD277, that are expressed on tumor cells and this interaction helps stimulate gamma delta T cell activation and tumor recognition (3). Considering their role in tumor recognition and killing, gamma delta T cells and the TCRs may be leveraged for cancer immunotherapies (3,4,6). Strategies for utilizing gamma delta T cells in immunotherapy include chimeric antigen receptor (CAR) transduction in gamma delta T cells, in vivo activation of gamma delta cells with anti-BTN3A1 monoclonal antibodies, or bispecific gamma delta T cell engagers (6).
References
1. Morath, A., & Schamel, W. W. (2020). AB and GD T cell receptors: similar but different. Journal of Leukocyte Biology, 107(6), 1045-1055. https://doi.org/10.1002/JLB.2MR1219-233R
2. Zarin, P., Chen, E. L., In, T. S., Anderson, M. K., & Zuniga-Pflucker, J. C. (2015). Gamma delta T-cell differentiation and effector function programming, TCR signal strength, when and how much?. Cellular Immunology, 296(1), 70-75. https://doi.org/10.1016/j.cellimm.2015.03.007
3. Silva-Santos, B., Serre, K., & Norell, H. (2015). GD T cells in cancer. Nature Reviews. Immunology, 15(11), 683-691. https://doi.org/10.1038/nri3904
4. Hahn, A. M., & Winkler, T. H. (2020). Resolving the mystery-How TCR transgenic mouse models shed light on the elusive case of gamma delta T cells. Journal of Leukocyte Biology, 107(6), 993-1007. https://doi.org/10.1002/JLB.1MR0120-237R
5. Fichtner, A. S., Ravens, S., & Prinz, I. (2020). Human GD TCR repertoires in health and disease. Cells, 9(4), 800. https://doi.org/10.3390/cells9040800
6. Kabelitz, D., Serrano, R., Kouakanou, L., Peters, C., & Kalyan, S. (2020). Cancer immunotherapy with gammadelta T cells: many paths ahead of us. Cellular & Molecular Immunology, 17(9), 925-939. https://doi.org/10.1038/s41423-020-0504-x
Additional TCR gamma/delta Products
Product Documents for TCR gamma/delta Antibody (7A5)
Product Specific Notices for TCR gamma/delta Antibody (7A5)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...